Brexit and the rise of nationalism in Europe could hinder patients’ access to pricey CAR-T therapies across Europe, a conference heard.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,